These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 2844087)

  • 21. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F; van den Broek SA; Bory M
    Am J Cardiol; 1992 Oct; 70(10):78C-83C. PubMed ID: 1329478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH
    Cardiology; 1991; 79 Suppl 1():22-9. PubMed ID: 1655262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
    Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
    Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisinopril versus placebo in older congestive heart failure patients.
    Lewis GR
    Am J Med; 1988 Sep; 85(3B):48-54. PubMed ID: 2844088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
    Langtry HD; Markham A
    Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators.
    Lang RM; DiBianco R; Broderick GT; Gottlieb SS; Kostis J; Lyle PA; Makris L; Rajfer SI; Rucinska EJ
    Am Heart J; 1994 Sep; 128(3):551-6. PubMed ID: 8074019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ACE inhibitors and heart failure].
    Franchi F; Puddu GM
    Clin Ter; 1990 Mar; 132(6):419-22. PubMed ID: 2158409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long- versus short-acting angiotensin-converting enzyme inhibitors.
    Ikram H; White HD
    J Am Coll Cardiol; 1990 Jan; 15(1):250-1. PubMed ID: 2153158
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
    DiBianco R
    Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
    Jessup M
    J Am Coll Cardiol; 1989 May; 13(6):1248-50. PubMed ID: 2539404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.